Pudong-Based Drug Maker Gensciences Takes "Made in Shanghai" Global   2024-01-22

Recently, Gensciences, a drug company located in the Zhangjiang Innovative Pharmaceutical Industry Base, received the FDA approval of IND for its new-generation ultra-long-acting recombinant FVIII pro

To view the full text or download it, please log in with the form on the right.

If you haven’t sign up with us, click here to sign up for free.